We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News   Jun 21, 2018 | Original story from PhoreMost

 
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

Dr Chris Torrance, CEO at PhoreMost Ltd

 
 
 

RELATED ARTICLES

Dramatic Increase in E-Cigarette Use Among Youth

News

Sharp rise in e-cigarette use results in uptick in overall tobacco product use; prompts new, forceful steps by FDA to firmly confront and reverse youth epidemic.

READ MORE

Rainforest Vine Compound Starves Pancreatic Cancer Cells

News

Researchers have identified a compound from a Congolese plant that has strong "antiausterity" potential, making pancreatic cancer cells susceptible to nutrient starvation.

READ MORE

Non-circulating T Cells Vital for Protection against Salmonella

News

Noncirculating T cells are relatively unknown, but appear to be a vital component of immunity to Salmonella infection — and should be the focus of vaccine strategies.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE